In PD-1-positive SCLC samples, tumor-infiltrating lymphocytes (TILs) are typically located at the tumor-stroma interface, with limited presence among cancer cells, although more CD8+ T cells are observed at the tumor margins (122, 126). The gene discussed is CD8A; the disease is neoplasm.